Gene Query: LUC7L2

Dataset Description Geneva Score
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 35.25
Comparative Transcriptomics of Triple Negative Breast Cancer Stem Cells and Differentiated Tumor Cells Identifies Teneurin-4 as a Potential Therapeutic Target 28.54
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 25.71
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 21.81
ONECUT2 Drives Neuroendocrine Prostate Cancer Through Hypoxia Signaling 21.73
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 21.16
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 21.15
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 21.12
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 20.58
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 19.19
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 18.77
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 18.77
Determination of tRNA aminoacylation levels by high throughput sequencing 18.07
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 17.92
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 17.55
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 17.44
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 16.84
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 16.75
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 16.58
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 16.16
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 15.88
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 14.72
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 14.51
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 14.51
A transcriptome-wide divergence in protein translation scales with LIN28B expression 14.17
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 13.94
LNCaP treated with iBET 13.81
RNAseq of HEK293 cells after Chtop knockdown 13.8
Co-transcriptional loading of RNA export factors shapes the human transcriptome 13.8
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 13.58
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 13.33
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 13.16
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 13.16
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 12.89
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 12.8
3’ Uridylation Expands miRNA Target Repertoire 12.79
Differentiation enhances Zika virus infection in neuronal brain cells 12.71
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 12.64
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 12.49
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 12.43
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 12.43
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 12.43
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 12.28
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 12.16
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 12.11
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 12.08
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 12.07
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 11.5
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 11.28
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 11.13
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 11.08
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 10.98
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 10.92
IMP3 regulated gene expression in breast cancer cells 10.8
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 10.73
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 10.62
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 10.59
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 10.45
Differentially expressed genes post knock down of lincDUSP26 10.41
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 10.36
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 10.34
Genes significantly down or Up-regulated upon RNF219 knockdown 10.33
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 10.17
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 10.17
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 10.02
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 9.95
Control of prostate tumour growth by the long non-coding RNA GHSROS 9.95
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 9.81
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer (RNA-Seq) 9.79
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancer 9.79
Solid phase chemistry to covalently and reversibly capture thiolated RNA 9.79
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 9.75
The DPYSL2 gene connects mTOR and schizophrenia 9.69
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 9.56
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 9.54
miR-450a acts as a tumor suppressor in ovarian cancer by readjusting energy metabolism 9.53
RNA-seq analyses of human prostate cancer cells 9.49
9.43
The interplay between SOX4 and SMAD3 in the context of breast cancer 9.34
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 9.22
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 9.18
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress [human] 9.08
mitoCPR - a surveillance pathway that protects mitochondria in response to mitochondrial import stress 9.08
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 8.95
Genome wide expression change by RNF168 knocking down in NEC cells 8.95
Human embryonic stem cells in E8 and AKIT culture medium 8.94
Growth factor-free, chemically-defined culture system for expansion and derivation of human pluripotent stem cells 8.94
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 8.89
CROP-Seq in Primary Human T Cells 8.84
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 8.83
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 8.79
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 8.74
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 8.7
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 8.67
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 8.66
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 8.6
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 8.6
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 8.45
Genome wide expression change in LCC2 and MCF-7 cells 8.43
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 8.4
CD73 knockdown effect in pancreatic cancer cell lines 8.39
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 8.32
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 8.24
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 8.16
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 8.11
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 8.11
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 8.1
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 8.06
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 8.05
Spliceosomal disruption of the non-canonical BAF complex in cancer 8.04
Genome wide expression change by RNF168 knocking down in MCF-7 cells 8.02
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 8.02
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 7.98
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 7.97
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 7.95
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 7.95
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 7.95
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 7.92
7.9
IRF1 regulates IFN dependent and independent gene expression 7.85
Uridylation by TUT4 and TUT7 marks mRNA for degradation 7.81
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 7.79
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 7.78
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 7.73
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 7.71
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 7.69
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 7.69
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 7.63
Improved post thaw function and genetic changes for mesenchymal stromal cells cryopreserved using multicomponent osmolyte solutions 7.58
MYC dependent mRNA translation shapes gene expression and cell biology 7.57
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 7.52
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 7.48
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma [RNA-seq] 7.45
The SS18-SSX oncoprotein hijacks KDM2B-PRC1.1 to drive synovial sarcoma 7.45
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 7.41
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 7.41
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 7.4
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 7.38
Inhibition of TNBC metastasis by Gpx1 7.36
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 7.31
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 7.26
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 7.22
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 7.19
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 7.18
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 7.17
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 7.11
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 7.1
RNA-seq of MDA-MB-231 cells with TET1 knockout 7.09
NRDE2 negatively regulates nuclear exosome functions 7.07
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 7.06
Hepatocyte maturation 7.06
Integrating single-cell transcriptomic data across different conditions, technologies, and species 7.02
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 7.01
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 7.01
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 6.98
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 6.97
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 6.92
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 6.87
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 6.87
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 6.86
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 6.84
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 6.84
Global analysis of enhancer targets: Mosaic-seq 6.8
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 6.79
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 6.79
Global response to chemotherapy-induced apoptosis 6.78
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 6.76
RNA transcriptome analysis during HSV-1 infection 6.75
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 6.73
Comparative Analysis of Cas9 Activators Across Multiple Species 6.71
Transcriptional profiling of LS1034 cells treated with tepoxalin 6.7
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 6.68
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 6.68
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 6.67
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 6.65
Transcriptomic analysis of the HOTAIR-regulated genes 6.64
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 6.63
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 6.63
FBXW7 modulates stress response by post-translational modification of HSF1 6.6
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 6.6
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 6.55
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 6.51
Identifying the molecular mode of action of itraconazole in colorectal cancer 6.5
Transcriptome analysis of BAP1 knockout and restoration 6.49
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 6.49
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 6.48
ARS2 is a general suppressor of pervasive transcription [RNAseq] 6.48
RNA editing in nascent RNA affects pre-mRNA splicing 6.45
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 6.35
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 6.35
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 6.33
High-throughput sequencing of PROMPT-enriched samples. 6.32
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 6.28
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 6.28
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 6.26
RNA-seq analysis of uveal melanoma cells treated with FR900359 6.24
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 6.23
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 6.23
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 6.22
mRNA expression profile of Lymphocytes 6.17
scRNASeq analysis of cycling cardiomyocytes 6.15
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 6.14
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 6.13
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 6.13
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 6.08
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 6.05
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 6.05
Systematic discovery of endogenous human ribonucleoprotein complexes 6.04
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 5.98
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 5.97
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 5.93
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 5.93
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 5.89
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 5.88
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 5.88
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 5.87
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 5.8
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 5.8
RNA sequencing of primary human platelets and in vitro cell lines 5.8
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 5.79
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 5.75
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 5.73
Capturing the Interactome of Newly Transcribed RNA 5.68
Capturing the Interactome of Newly Transcribed RNA (RICK) 5.68
Stage-specific human induced pluripotent stem cells map the progression of myeloid transformation to transplantable leukemia 5.67
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 5.66
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 5.63
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 5.61
Genome-wide discovery of human splicing branchpoints 5.58
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent (RNA-seq) 5.51
Cis-Regulatory Circuits Regulating NEK6 Kinase Overexpression in Transformed B Cells Are Super-Enhancer-Independent 5.51
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 5.47
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 5.41
K562 polyA RNA-Seq 5.41
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 5.4
Effect of drugs on transcriptomic profiles 5.37
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 5.37
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 5.36
RNA-sequencing in irradiated and normal A549 cells. 5.35
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 5.26
MARS Seq data from human cortical organoids 5.25
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 5.21
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 5.19
HEK293 Heat-shock experiment 5.17
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 5.16
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma 5.16
High resolution ChIP sequencing reveals novel bindings targets and prognostic role for SOX11 in Mantle cell lymphoma (RNA-Seq) 5.16
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 5.1
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 5.02
mRNA expression profiling in MDA-MB-231 (LM1) cells with a tet-incible MBD2 or p66α knock down, or treated with MBD2-targeting small molecule ABA or APC 5.02
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 4.99
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 4.95
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 4.94
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 4.94
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 4.91
A novel target of EZH1/2 for treatment of mantle cell lymphoma 4.9
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 4.84
single cell RNA-seq from GM12878 (ENCSR673UIY) 4.82
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 4.81
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 4.75
Transcriptome analysis of SKI knock-out in HL60 cells 4.75
Molecular Criteria for Defining the Naive Human Pluripotent State 4.74
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 4.72
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 4.69
Genome-wide functional assessment of enhancer activities in the human genome 4.67
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 4.65
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 4.64
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk 4.62
Coronary artery disease genes SMAD3 and TCF21 promote opposing interactive genetic programs that regulate smooth muscle cell differentiation and disease risk [RNA-seq] 4.62
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 4.57
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 4.57
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 4.45
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 4.44
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 4.41
HEXIM1 is induced by DHODH inhibition to suppress melanoma 4.41
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 4.34
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 4.3
Human cells contain natural double-stranded RNAs with potential regulatory capacity 4.27
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 4.25
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 4.23
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 4.22
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 4.21
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 4.19
Next Generation Sequencing upon siRNA-mediated knockdown of EIF5A in MCF-7 cells. 4.09
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 4.07
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 4.02
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 4.01
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 3.98
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 3.85
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 3.84
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 3.8
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 3.7
Defective structural RNA processing in relapsing-remitting multiple sclerosis 3.63
IQGAP3 interacts with Rad17 to activate the MRN/ATM/Chk2 signaling and promote radioresistance in lung cancer 3.61
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 3.61
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 3.59
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 3.53
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 3.52
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 3.5
SLIGRL-induced gene expression changes in NHEK cells 3.49
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 3.48
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 3.47
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 3.46
RNA-Seq of PRMT1 overexpression ECA109 cells 3.43
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 3.4
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 3.39
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq] 3.37
Targeting EZH2 in MYCN-amplified Neuroblastoma 3.37
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 3.37
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 3.35
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 3.34
Identification of renal resident macrophages across species 3.32
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 3.29
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 3.29
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 3.29
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 3.24
4sU-seq of HFF exposed to salt and heat stress 3.23
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 3.22
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 3.22
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 3.21
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 3.17
RNA polymerase in pre-B-ALL cell lines 3.17
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 3.16
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 3.14
Gene expression changes after LOC550643 silencing 3.12
Transcriptome analysis of peripheral blood monocytes 3.12
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 3.12
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 3.1
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 3.09
METTL3 and WTAP 3.09
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 3.08
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 3.06
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 3.01
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 2.98
MicroRNA-125a-5p overexpression in human macrophages 2.97
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 2.94
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 2.92
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 2.85
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 2.83
Genes significantly down or Up-regulated upon RNF219 knockdown. [RNA-Seq] 2.79
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 2.7
Total RNA profiles associated with DDX3 wild-type (WT) or R534H variant expression with or without sodium arsenite treatment [RNA-seq] 2.7
Profiles of ribosome-associated mRNAs regulated by expression of wild-type (WT) or R534H variant of DDX3 with or without Sodium Arsenite treatment 2.7
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 2.67
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 2.67
RNA-seq of cells with TET1 knockout 2.63
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 2.63
Interaction between mitoNEET and NAF-1 in cancer cells 2.59
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 2.58
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 2.48
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 2.48
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 2.44
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 2.43
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 2.39
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 2.35
FOXP1 orchestration of ASD-relevant signaling pathways. 2.35
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 2.32
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 2.31
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 2.31
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 2.23
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 2.23
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 2.19
Measure transcript integrity using RNA-seq data 2.16
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 2.15
mRNA recovered upon RNF219 IP. [RNA-IP] 2.12
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 2.08
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 2.06
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 2.05
Transcriptome of human ILC2s; primary vs IL-1b-primed 2.04
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 2.03
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 2.01
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 2.0
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 1.99
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 1.97
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 1.96
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 1.96
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 1.96
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 1.95
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 1.95
Transposon-based construction of strand-specific RNA-seq libraries 1.94
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 1.92
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 1.86
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 1.85
The transcriptome effect of overexpressing EZH2 in MCF7 1.81
Human Treg IFNg/IL-10 subpopulations 1.77
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.76
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 1.7
HBEC-shp53-PCHD7 1.7
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 1.67
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 1.67
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 1.66
Parallel T-cell cloning and deep sequencing of the transcripts of human MAIT cells reveal stable oligoclonal TCRβ repertoire 1.63
Copper Regulation of HIF-1 Transcription Activity 1.6
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 1.6
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 1.59
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 1.59
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 1.57
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 1.54
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 1.51
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 1.5
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 1.49
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 1.49
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 1.46
Hypoxic transcriptome of SQ20B human head and neck cancer cells 1.45
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 1.42
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 1.42
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 1.4
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 1.34
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 1.34
SRSF1 role in cellular gene expression and splicing 1.34
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 1.31
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 1.31
Next generation sequencing of small RNAs isolated from exosomes in human semen 1.31
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 1.3
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 1.3
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 1.3
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 1.3
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 1.28
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 1.28
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 1.27
Induction of Cardiomyocyte Proliferation [pz-822_human] 1.27
RNA-Seq from human ILC transitional populations 1.25
Expression profiling of ILC transitional populations and Aiolos accessability and H3K27ac histone modifications in transfected MNK3 cells 1.25
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 1.25
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 1.24
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 1.22
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 1.2
An optimization system for isolating and sequencing of single human colon cancer cells 1.17
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 1.17
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 1.17
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 1.13
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 1.1
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 1.06
Primate-specific gene TMEM14B promotes cortical expansion and folding 1.03
nELAVL HITS-CLIP in Alzheimer's Disease patients 1.0
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 1.0
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 0.99
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.97
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.96
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 0.95
Regulation of poly(A) tail and translation during the somatic cell cycle 0.94
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 0.93
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 0.93
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 0.91
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 0.9
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 0.9
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 0.86
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 0.79
Effect of ILF3 on translation during homeostasis and the antiviral response 0.79
Aging-associated patterns in the expression of human endogenous retroviruses 0.74
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.71
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.71
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.71
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.6
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.6
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 0.57
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 0.55
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 0.55
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 0.53
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 0.53
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 0.51
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.5
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.47
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.47
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.46
Identification of renal resident macrophages across species [C1] 0.45
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 0.45
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 0.4
RNA-seq of primary patient AML samples 0.38
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 0.37
Transcriptome-wide modulation of splicing by the exon junction complex 0.37
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.35
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.34
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.33
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 0.33
ADAR1-editing of cellular and measles virus-derived duplex RNA 0.33
TT-seq captures simultaneous activation of eRNAs and promoters during T cell activation 0.32
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.3
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 0.24
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 0.22
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 0.22
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.2
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 0.19
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 0.19
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.18
Modulation of nonsense-mediated decay by rapamycin 0.17
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.16
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 0.16
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 0.14
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.14
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.13
STX4 Over-Expression in Human islets 0.12
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 0.12
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.03
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.03
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.03
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.03
Suppression of the FOXM1 transcriptional program via novel small molecule inhibition 0.02
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.02
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation